F-19 imaging, both spectrally resolved and unresolved, appears to be of great interest to the medical community. A complete lack of natural background and high tolerance of the body to certain fluorinated compounds (anesthetics and blood substitution agents) make F-19 imaging an attractive possibilty (Ref. 4,5,6).
Currently, in vivo F-19 spectroscopic expertise may be divided into four areas:
Anesthesiology - spectroscopy and bio-distributionof fluorinated agents such as halothane, methoxyfluorane, and isofluorane in animal brain, muscle, and tumors (Ref. 7,8,9,10,11,12,13,14). These studies demonstrate previously unobtainable data on the distribution and chemistry of commonly used anesthetic agents. it can be anticipated that human use will produce significant benefits in optimizing dose, in minimizing side effects, and in investigating brain function.
Vascular function - studies of cardiac function, blood flow, oxygen perfusion, and oxygen transfer in blood substitutes (Ref. 15,16,17,18,19,20,21). Assessment of organ perfusion (cerebral and kidney perfusion) using direct methods is possible leading to potential elimination of less effective radiographic or nuclear medicine techniques which carry a greater risk. Direct measurement of oxygen concentrations and oxygen effects can be observed.
Brain metabolism - studies of local cerebral glucose utlization rates by PET with the radiolabeled glucose analog 2-fluoro-2-deoxy-D-glucose (2FDG) suffer from a lack of chemical specificity. F-19 NMR resolves this problem by producing direct evidence of phosphorylation at high rates and can show persistance in the brain with time constants much longer than the half-life of the F-18 radionucleus used by PET studies (Ref 22,23,24,25,26,27).
Drug metabolism - previously used in following the competing catabolic pathway of chemotherapuetic agents in animals and humans. The very common chemotherapy drug, 5-fluorouracil, and its derviatives has been extensively studied with F-19 NMR (Ref. 28,29,30,31,32,33,34,35,36,37). Delivery of the drug to tumors sites as well as catabolism in the liver has been studied in humans and appears to have significantpotential in enhancement of the course of therapy.
F-19 spectra of a well known fluorinated chemotherapeutic drug, 5-fluorouracil, and its metabolites can be obtainable in the liver and in tumors of patients undergoing cancer chemotherapy (Ref. 34,35,36,37).
![]() |
![]() |
(WIP - works in progress)